The purpose of this study is to assess the effectiveness of RaPID/BSI by testing its performance compared to blood cultures collected prospectively from consented subjects.
Study Type
OBSERVATIONAL
Enrollment
225
RaPID/BSI Test
HelixBind Inc.
Marlborough, Massachusetts, United States
RECRUITINGSensitivity and Specificity compared to Blood Culture (comparator method)
The primary endpoint of sensitivity (detection of on panel pathogen) and specificity will be determined by comparing blood culture results with the RaPID/BSI results from the prospective clinical specimens.
Time frame: Up to 24 hours following blood collection
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.